Avatar photo

Ron Finklestien

“Akero Therapeutics Unveils AI-Driven Insights Confirming Efruxifermin’s Antifibrotic Efficacy in Phase 2b HARMONY Trial for Pre-Cirrhotic MASH”

Akero’s Efruxifermin Shows Promise in Treating Pre-Cirrhotic MASH New analyses from Akero demonstrate the antifibrotic activity of efruxifermin (EFX) in patients with pre-cirrhotic metabolic ...

Citigroup Lowers Rating on Wolfspeed (BMV:WOLF)

Citigroup Downgrades Wolfspeed, Shareholder Actions Noted Fintel reports that on May 9, 2025, Citigroup revised its outlook for Wolfspeed (BMV:WOLF) from Neutral to Sell. ...

Forecast: Palantir Poised to Achieve a Trillion-Dollar Valuation by 2030

Palantir Technologies Sees Significant Growth Amid Market Challenges Palantir Technologies (NASDAQ: PLTR) has made impressive strides in 2025, showing a year-to-date increase of 43%. ...

“Dollar General vs. Dollar Tree: Distinct Strategies and Implications for Investors”

Dollar General vs. Dollar Tree: A Closer Look at Financial Dynamics At first glance, Dollar Tree (NASDAQ: DLTR) and Dollar General (NYSE: DG) may ...

“Cathie Wood’s Latest Find: An Underrated AI Chip Stock She Just Invested In (It’s Not Nvidia!)”

Cathie Wood Bets Big on Advanced Micro Devices Amid AI Chip Surge As CEO and chief investment officer at Ark Invest, Cathie Wood has ...

Top 2 Must-Consider AI Stocks for Immediate Investment

Investors Eye Nvidia and TSMC Amid AI Infrastructure Spending Many investors are closely monitoring large technology firms as they pour substantial capital into artificial ...

Seaport Global Initiates Neutral Coverage on QUALCOMM (BMV:QCOM)

Seaport Global Initiates Neutral Coverage on QUALCOMM Amid Fund Activity Fintel reports that on May 9, 2025, Seaport Global initiated coverage of QUALCOMM (BMV:QCOM) ...

AI Takes to the Open Road: What’s Ahead for the Future of Driving

# Self-Driving Trucks Mark a Turning Point for America’s Workforce The latest advancements in self-driving technology may significantly impact various sectors, particularly trucking. Charlie’s ...

Madrigal Pharmaceuticals Celebrates Two-Year Success of Rezdiffra in Phase 3 MAESTRO-NAFLD-1 Trial for MASH Cirrhosis

Madrigal Pharmaceuticals Unveils Promising Two-Year Results for Rezdiffra Madrigal Pharmaceuticals has announced significant findings from a two-year trial of their drug Rezdiffra, demonstrating improvements ...

“Is Now the Right Moment to Invest in AMD Stock Ahead of its AI Expansion?”

AMD Reports Growth Amid Challenges and Export Restrictions When Advanced Micro Devices (NASDAQ: AMD) unveiled its first-quarter results recently, it highlighted promising indicators for ...